Literature DB >> 17606804

Symposium. The introduction of biologics in orthopaedics: issues of cost, commercialism, and ethics.

William T Obremskey1, James S Marotta, Michael J Yaszemski, Larry R Churchill, Scott D Boden, Douglas R Dirschl.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17606804     DOI: 10.2106/JBJS.F.01185

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


× No keyword cloud information.
  5 in total

Review 1.  Current status of bone graft options for anterior interbody fusion of the cervical and lumbar spine.

Authors:  Anthony Minh Tien Chau; Lileane Liang Xu; Johnny Ho-Yin Wong; Ralph Jasper Mobbs
Journal:  Neurosurg Rev       Date:  2013-06-07       Impact factor: 3.042

2.  Platelet-rich plasma in mono-segmental posterior lumbar interbody fusion.

Authors:  J Sys; J Weyler; T Van Der Zijden; P Parizel; J Michielsen
Journal:  Eur Spine J       Date:  2011-07-10       Impact factor: 3.134

Review 3.  Bone grafts, bone substitutes and orthobiologics: the bridge between basic science and clinical advancements in fracture healing.

Authors:  Timothy T Roberts; Andrew J Rosenbaum
Journal:  Organogenesis       Date:  2012-10-01       Impact factor: 2.500

Review 4.  The Use of Bone Grafts, Bone Graft Substitutes, and Orthobiologics for Osseous Healing in Foot and Ankle Surgery.

Authors:  Jonathan R Peterson; Fangyu Chen; Eugene Nwankwo; Travis J Dekker; Samuel B Adams
Journal:  Foot Ankle Orthop       Date:  2019-07-10

5.  Necrotizing fasciitis of the extremity caused by Haemophilus influenzae serotype b in a healthy adult.

Authors:  Ellen Y Lee; Wing Yuk Ip
Journal:  Clin Orthop Relat Res       Date:  2009-10-17       Impact factor: 4.176

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.